Our data were consistent with studies from other investigators, which revealed that positive p53 expression was associated with unfavorable clinicopathologic characteristics and a poor prognosis of gastric cancer patients who have undergone curative gastrectomy [28]–[30]. Here, TP53 is linked to gastric cancer.